Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy

Table 4 SBRT group

Study number	Author	Number of patients	5y-bRFS	Total dose (D)	Fractions (N)	D²/N (C)	Definition of bRFS^b
1	Bolzicco	100	0.944	35	5	245	P
2	Kang	44	0.936	34	4	289	P
3	King	1100	0.93	36.25	5	262.8	P
	King	385	0.925	35	5	245	P
	King	589	0.907	36.25	5	262.8	P
	King	126	0.958	39	5	304.2	P
4	Lee	45	0.897	36	5	259.2	P
5	Loblaw	84	0.98	35	5	245	P
6	Mantz	102	1	40	5	320	P
7	Meier	309	0.971	40	5	320	P
8	Tsang	43	0.92	36.25	5	262.8	P

ISSN: 1748-717X